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Summary. — 67Cu, 186Re and 47Sc are theranostic radionuclides in the spot-light
of the scientific community: the insufficient availability is limiting their use in clinical
and pre-clinical studies. The aim of this work is the analysis of 47Sc production by
using high-energy and high-intensity cyclotrons, as the one installed at INFN-LNL
in the framework of SPES project, by exploring promising nuclear reactions induced
by proton-beams.
1. – Introduction
The worldwide increasing interest on theranostic radiopharmaceuticals, allowing the
selection of patients with higher chance to respond to specific treatments and the ap-
plication of individually customized dosimetry, is well represented by the recent Coordi-
nated Research Project (CRP), promoted by the International Atomic Energy Agency
(IAEA), focused on 67Cu, 186Re and 47Sc as Emerging Theranostic Radionuclides (No.
F22053) [1]. The aim of this work is the analysis of 47Sc production by using proton
cyclotrons, as the one installed at INFN-LNL in 2015. The applied research in the field
of nuclear medicine through the LARAMED project, acronym of LAboratory of RA-
dionuclides for MEDicine, is currenty conducted in partnership with different italian and
international research institutions, since the infrastructure at LNL (beam-lines and lab-
oratories) is currently under construction. Cross section measurements are carried out
at the ARRONAX facility (Nantes, France), where a 70 MeV cyclotron is operative and
produces radionuclides for medicine [2]. Among the isotopes of interest for LARAMED
and ARRONAX, 47Sc is of particular interest for its great potential in theranostic but
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Fig. 1. – Photograph of the foils of a stacked-target.
also in radioimmunotherapy: its relatively long half-life (3.3492 d) permits to follow the
slow biodistribution of monoclonal antibodies; the β− particles of low-medium energy
(mean energy 162.0 keV; intensity 100%) are useful to deliver cytotoxic dose to small-
medium sized tumours while the emitted γ−rays are suitable for SPECT or SPECT/CT
cameras (energy 159.381 keV; intensity 68.3%). Moreover, β+ counterparts such as 44Sc
or 43Sc exist and may also allow the theranostic approach to be used with PET imaging.
The PASTA project, acronym of Production with Accelerator of Sc-47 for Theranostic
Applications, is focused on the production of 47Sc by using enriched metal targets of 48Ti,
49Ti, 50Ti and natV metal targets. In fact, no experimental data are available for the
49Ti(p,x)47Sc reaction, while only few measurements were performed with the 48Ti and
50Ti targets in oxide form [3]. In view of an optimized production, the co-production of
contaminant radionuclides, especially the isotopic impurities that cannot be chemically
separated from the desired product and affect the RadioNuclidic Purity (RNP), is a
keypoint. For this reason, experiments are designed in order to measure not only the
nuclear cross section of the radionuclide of interest (i.e. 47Sc), but also the production
of isotopic contaminants (e.g. 46Sc) and other impurities (e.g. 51Cr) that may affect the
radiochemical procedure aimed at the radionuclide extraction and purification.
2. – Materials and Methods
Considering the high cost of the enriched metal powders 49Ti and 50Ti (natural abun-
dance 5.41% and 5.18% respectively), first experiments at the ARRONAX facility were
performed with natV and 48Ti (natural abundance 73.73%) metal targets, arranged in
stacked-foils structures (fig.1). The natV metal foils were purchased by Goodfellow, while
enriched 48Ti metal targets were realized by using the High energy VIbrational Powders
Plating (HIVIPP) method [4], to homogeneously deposit the enriched titanium powder
(>99%, purchased by TraceScience) on an aluminium support. Considering the use of
enriched expensive materials, a dedicated target holder ( 11 mm), a graphite collima-
tor ( 9 mm) and a plastic support have been designed and realized at the INFN-LNL
workshop and used to precisely define the beam size on target during these irradiation
runs. The duration of a typical run was 1.5 h with a constant current of about 100 nA,
monitored during the bombardment by using an instrumented beam dump.
In the meantime, a fruitful collaboration with experts in nuclear codes such as EM-
PIRE, FLUKA and TALYS [5-7] started, in order to compare the different nuclear re-
actions and identify the most promising energy region for 47Sc production. Among the
radionuclidic impurities of 47Sc coproduced during the irradiation, 46Sc (83.79 d half-
life) causes the major concern since it is the only radioisotope with a longer half-life than
47Sc. For this reason, a cooling time after irradiation may only decrease the 47Sc/ 46Sc
activity ratio: it is thus crucial to minimize as much as possible the 46Sc production by
carefully selecting the target material and the energy range. Aiming at this goal, the
different nuclear codes are employed to estimate the cross sections to produce 47Sc and
46Sc by using the enriched and expensive material of interest (49Ti and 50Ti).
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Fig. 2. – Preliminary results of the 48Ti(p,x)47Sc,46Sc nuclear cross sections (red dots).
3. – Results and Discussion
Figure 2 shows the preliminary results of the measurement of 48Ti(p,x)47Sc,46Sc nu-
clear cross sections (red dots). The reaction for 46Sc production shows a regular trend
in the entire energy range investigated; on the contrary, the trend of the 48Ti(p,x)47Sc
cross section is irregular at around 30-35 MeV; however, data anlysis is still in progress.
Preliminary results of the natV(p,x)47Sc, 46Sc cross sections are shown in fig.3 (red
dots) and compared with previous measurements [3]. In both cases an overall good
agreement can be found with previous measurements; however, in the energy range 50-
60 MeV our values for 47Sc production seems to be lower than previous data. For brevity,
results regarding the production of 44mSc, 44Sc, 48Sc, 43Sc, 43K, 48V, 48Cr, 49Cr and 51Cr
are not shown here; in case of 44mSc and 44Sc decay contribution was taken into account
in the data analysis; for 43Sc, the interference with the γ−ray at 373 keV emitted by 43K
was corrected; in case of 48Sc, the nuclear cross section is calculated by considering the
γ−rays at 175 keV and 1037 keV, in order to avoid the interference with 48V at the 938
keV and 1312 keV γ−lines.
Figure 4 reports the theoretical estimations of 47Sc/46Sc cross section ratio for 49Ti
(left) and 50Ti (right) by using FLUKA (blue line), TALYS (red line) and EMPIRE
Fig. 3. – Preliminary results of the natV(p,x)47Sc,46Sc nuclear cross sections (red dots).
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Fig. 4. – 47Sc/46Sc cross section ratio for 49Ti (left) and 50Ti (right) targets.
(brown line) nuclear codes. These estimations show that the nuclear reaction on 49Ti
may be preferable than the nuclear reaction on 50Ti targets: in particular, the most
promising energy range with 49Ti enriched material is 25-45 MeV; on the contrary, in
case of 50Ti targets the best energy range is at higher energies, i.e. EP > 40 MeV.
4. – Conclusion
This work reports preliminary results of the PASTA project, an interdisciplinary
research activity that ranges from nuclear physics up to material science and radiochem-
istry.
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